The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 18 Oct 2005
doi: 10.1242/jcs.02629
Research Article
Chemotaxis towards hyaluronan is dependent on CD44 expression and modulated by cell type variation in CD44-hyaluronan binding
George Tzircotis,
Rick F. Thorne,
and
Clare M. Isacke*
* Author for correspondence (e-mail: clare.isacke{at}icr.ac.uk)
The accumulation of the extracellular matrix glycosaminoglycan hyaluronan by tumours and tumour-associated stroma promotes cancer cell invasion and metastasis. Using the Dunn chamber chemotaxis assay, we demonstrate for the first time that high molecular mass hyaluronan acts as a soluble chemoattractant promoting the directional migration of MDA-MB-468 and MDA-MB-231 breast cancer cells. Moreover, chemotaxis towards hyaluronan, but not foetal bovine serum, can be abrogated following treatment of the cells with siRNA oligonucleotides to downregulate CD44 expression. These data indicate that CD44 is the principal receptor mediating this response and that CD44 expression is not a general requirement for cell migration and gradient sensing, rather it elicits a ligand-specific response. However, expression of CD44 alone is not sufficient to drive chemotaxis towards hyaluronan, as NIH-3T3 fibroblasts were unable to respond to a hyaluronan gradient even when transfected with high levels of human CD44. For NIH-3T3 cells to bind exogenous hyaluronan, it was necessary to both increase the level of receptor expression and remove a hyaluronan pericellular matrix. Together, these studies reveal a direct mechanism for promoting cell invasion into the hyaluronan-rich matrix and predict that in the complex multicellular environment in vivo, multiple mechanisms exist to regulate the ability of a cell to respond to a chemotactic hyaluronan gradient.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
E. A Craig, P. Parker, and T. D Camenisch
Size-dependent regulation of Snail2 by hyaluronan: Its role in cellular invasion
Glycobiology,
August 1, 2009;
19(8):
890 - 898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Monypenny, D. Zicha, C. Higashida, F. Oceguera-Yanez, S. Narumiya, and N. Watanabe
Cdc42 and Rac Family GTPases Regulate Mode and Speed but Not Direction of Primary Fibroblast Migration during Platelet-Derived Growth Factor-Dependent Chemotaxis
Mol. Cell. Biol.,
May 15, 2009;
29(10):
2730 - 2747.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Vigetti, M. Viola, E. Karousou, M. Rizzi, P. Moretto, A. Genasetti, M. Clerici, V. C. Hascall, G. De Luca, and A. Passi
Hyaluronan-CD44-ERK1/2 Regulate Human Aortic Smooth Muscle Cell Motility during Aging
J. Biol. Chem.,
February 15, 2008;
283(7):
4448 - 4458.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Sturge, S. K. Todd, G. Kogianni, A. McCarthy, and C. M. Isacke
Mannose receptor regulation of macrophage cell migration
J. Leukoc. Biol.,
September 1, 2007;
82(3):
585 - 593.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Hamilton, S. F. Fard, F. F. Paiwand, C. Tolg, M. Veiseh, C. Wang, J. B. McCarthy, M. J. Bissell, J. Koropatnick, and E. A. Turley
The Hyaluronan Receptors CD44 and Rhamm (CD168) Form Complexes with ERK1,2 That Sustain High Basal Motility in Breast Cancer Cells
J. Biol. Chem.,
June 1, 2007;
282(22):
16667 - 16680.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. C. Harrell, W. W. Dye, D. C. Allred, P. Jedlicka, N. S. Spoelstra, C. A. Sartorius, and K. B. Horwitz
Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes.
Cancer Res.,
September 15, 2006;
66(18):
9308 - 9315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ori, M. Nardini, P. Casini, R. Perris, and I. Nardi
XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development
Development,
February 15, 2006;
133(4):
631 - 640.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2005
